Entity
  • DISCO Pharmaceuticals GmbH

    Created in 2022
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    1,073
  • Activities

  • Technologies

  • Entity types

  • Location

    Gottfried-Hagen-Straße 62, 51105 Köln, Germany

    Köln

    Germany

  • Employees

    Scale: 11-50

    Estimated: 24

  • Engaged corporates

    1
    1 0
  • Added in Motherbase

    9 months ago
Description
  • Value proposition

    The surfaceome company.

    DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D. The technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner, thus addressing the need for target candidates for both mono- and bi-specific antibodies. These insights enable the development of a multitude of cancer-selective therapies, with the potential to boost efficacy and reducing side effects for patients.

Corporate interactions BETA
Corporate TypeTweets Articles
Sofinnova Partners
Sofinnova Partners
Financial Services
Sofinnova Partners
Financial Services
Other

3 Sep 2024


Similar entities
Loading...
Loading...
Social network dynamics